Aethlon Medical(us:AEMD)

    0.5659

    -2.43%

    Updated on 2024-12-23

    Open:0.5394
    Close:0.5659
    High:0.6490
    Low:0.5170
    Pre Close:0.5800
    Volume:5.03M
    Amount:2.95M
    Turnover:36.00%
    Shares:13.96M
    MarketCap:7.90M
    DateTotalTotal SharesTotal RatioNewIncreasedDecreased
    2024-06-30181813061.30%822
    2024-03-3111519701.98%022
    2023-12-3124520972.01%0220
    2023-09-3027772080.31%2510
    2023-06-30297503553.02%3212
    2023-03-313210183844.43%3610
    2022-12-313712991295.66%8616
    2022-09-303419717808.59%996
    dateorgNametotalratiochangeShareschangeRatio
    2024-03-31Vanguard Group Inc212240.81%0
    2024-03-31Geode Capital Management, Llc202740.77%0
    2024-03-31Blackrock Inc.73400.28%0
    2024-03-31Group One Trading, L.P.12170.05%-101-7.66%
    2024-03-31Tower Research Capital Llc (Trc)11370.04%575.28%
    2024-03-31Osaic Holdings, Inc.2990.01%0
    2024-03-31Wells Fargo & Company/Mn2300.01%0
    2024-03-31Ubs Group Ag1340.01%73119.67%
    2024-03-31Morgan Stanley890.00%0
    2024-03-31Bartlett & Co. Wealth Management Llc260.00%0

    About

    Aethlon Medical, Inc. is a medical technology company which focuses on developing products to diagnose and treat life and organ threatening diseases. It develops Aethlon Hemopurifier, which is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. The firm operates through the following segments: Aethlon and ESI. The Aethlon segment is involved in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce in 1991 and is headquartered in San Diego, CA.
    Address:11555 Sorrento Valley Road,Suite 203

    Market Movers